{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:25:46Z","timestamp":1754162746307,"version":"3.41.2"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>IMPORTANCE AND OBJECTIVES:<\/jats:title>\n            <jats:p>Inhaled volatile anesthetics are employed as rescue therapy in near-fatal asthma, despite limited evidence. This study aims to describe the characteristics, management, and outcomes of mechanically ventilated adult patients with near-fatal asthma, stratified by the use of volatile anesthetic therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective single-center observational cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Tertiary critical care and extracorporeal membrane oxygenation (ECMO) unit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PARTICIPANTS:<\/jats:title>\n            <jats:p>Adults 16 years old or older receiving mechanical ventilation (MV) for greater than or equal to 24 hours and\/or ECMO between January 2016 and August 2023 for near-fatal asthma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOMES AND MEASURES:<\/jats:title>\n            <jats:p>We recorded demographics, disease severity tidal volumes, and ventilator settings, by treatment over the first 100 hours. Outcomes were duration of ECMO and MV, ICU length of stay, 90-day mortality, and adverse drug reaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Sixty-two patients were included (62.9% female), with a median (interquartile range [IQR]) age of 45 years (29\u201351 yr). Median (IQR) pH 7.13 (6.93\u20137.23), Pa<jats:sc>co<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> 12.9 kPa (8.7\u201316.2 kPa), and tidal volume 178 mL (50\u2013300 mL). Most patients received IV bronchodilators and 32 (51.6%) required ECMO. Thirty-eight patients (61.3%) were treated with volatile anesthetics. Volatile patients had worse ventilation and blood gas parameters before treatment, more barotrauma, and were more likely to be receiving ECMO. Despite this, improvements in tidal volume occurred in the volatile group (mean increase, 204 mL [83.9%]; 95% CI, 110\u2013298; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Median (IQR) duration of MV and ICU length of stay in volatile and no volatile patients were 10 days (8\u201316 d) vs. 5 days (3\u201310 d; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001) and 15 days (13\u201320 d) vs. 9 days (7\u201314 d; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001), respectively. ICU and 90-day mortality in volatile and no volatile patients were 5.3% vs. 4.2%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS AND RELEVANCE:<\/jats:title>\n            <jats:p>The use of inhaled volatile anesthetics for near-fatal asthma, including during ECMO, appears to be feasible and safe, and with favorable clinical outcomes; however, no conclusions regarding efficacy can be directly inferred.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001295","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:21Z","timestamp":1753891221000},"page":"e1295","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics and Outcomes of Patients Receiving Volatile Anesthetics in Near-Fatal Asthma: A Retrospective Observational Cohort Study"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5600-8368","authenticated-orcid":false,"given":"Christopher","family":"Remmington","sequence":"first","affiliation":[{"name":"Departments of Pharmacy and Adult Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."},{"name":"Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Sciences and Centre for Human & Applied Physiological Sciences (CHAPS), School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Camporota","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy and Adult Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."},{"name":"Institute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Sciences and Centre for Human & Applied Physiological Sciences (CHAPS), School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Taylor","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy and Adult Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sousa","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy and Adult Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnaby","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy and Adult Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Glover","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy and Adult Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-011-8274-y","article-title":"The critically ill asthmatic\u2014from ICU to discharge.","volume":"43","author":"Louie","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-013-8395-6","article-title":"Definition of critical asthma syndromes.","volume":"48","author":"Kenyon","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"e0249889","DOI":"10.1371\/journal.pone.0249889","article-title":"Use of volatile agents for sedation in the intensive care unit: A national survey in France.","volume":"16","author":"Blondonnet","year":"2021","journal-title":"PLoS One"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/rccm.201512-2435CP","article-title":"Volatile anesthetics. Is a new player emerging in critical care sedation?","volume":"193","author":"Jerath","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/bja\/88.5.624","article-title":"Effects of anaesthetic agents on airway smooth muscles.","volume":"88","author":"Yamakage","year":"2002","journal-title":"Br J Anaesth"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00000542-199306000-00012","article-title":"Comparison of low concentrations of halothane and isoflurane as bronchodilators.","volume":"78","author":"Brown","year":"1993","journal-title":"Anesthesiology"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ddmod.2014.02.004","article-title":"Volatile anesthetics and the treatment of severe bronchospasm: A concept of targeted delivery.","volume":"15","author":"Mondo\u00f1edo","year":"2015","journal-title":"Drug Discov Today Dis Models"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1183\/09031936.02.00275702","article-title":"Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane.","volume":"20","author":"Mercier","year":"2002","journal-title":"Eur Respir J"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1164\/rccm.201604-0686OC","article-title":"Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study.","volume":"195","author":"Jabaudon","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bja.2024.03.031","article-title":"Clinical use and safety of volatile anaesthetic sedation in mechanically ventilated adult patients: A retrospective single-centre cohort study.","volume":"133","author":"Remmington","year":"2024","journal-title":"Br J Anaesth"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/EJA.0000000000001318","article-title":"Sevoflurane sedation and nephrogenic diabetes insipidus in patients affected with severe acute respiratory syndrome coronavirus 2.","volume":"38","author":"Coppola","year":"2021","journal-title":"Eur J Anaesthesiol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.bja.2019.02.009","article-title":"Nephrogenic diabetes insipidus associated with prolonged sedation with sevoflurane in the intensive care unit.","volume":"122","author":"L\u2019Heud\u00e9","year":"2019","journal-title":"Br J Anaesth"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma.","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/bja\/aeg132","article-title":"Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man.","volume":"91","author":"Nickalls","year":"2003","journal-title":"Br J Anaesth"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/bja\/82.6.852","article-title":"End-tidal sevoflurane concentration for tracheal extubation (MACEX) in adults: Comparison with isoflurane.","volume":"82","author":"Inomata","year":"1999","journal-title":"Br J Anaesth"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1213\/ANE.0000000000003452","article-title":"Halving the volume of AnaConDa: Evaluation of a new small-volume anesthetic reflector in a test lung model.","volume":"129","author":"Bomberg","year":"2019","journal-title":"Anesth Analg"},{"key":"R20-20250730","first-page":"e0310","article-title":"Volatile sedation for acute respiratory distress syndrome patients on venovenous extracorporeal membrane oxygenation and ultraprotective ventilation.","volume":"3","author":"Grasselli","year":"2021","journal-title":"Crit Care Explor"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1183\/09031936.02.00241502","article-title":"Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma.","volume":"19","author":"Plaza","year":"2002","journal-title":"Eur Respir J"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MAJ.0000000000000518","article-title":"Characteristics and prognosis of near-fatal asthma exacerbations.","volume":"350","author":"Gonzalez-Barcala","year":"2015","journal-title":"Am J Med Sci"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13054-017-1886-8","article-title":"Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: Analysis of the Extracorporeal Life Support Organization registry.","volume":"21","author":"Yeo","year":"2017","journal-title":"Crit Care"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000542-199909000-00019","article-title":"Direct cerebral vasodilatory effects of sevoflurane and isoflurane.","volume":"91","author":"Matta","year":"1999","journal-title":"Anesthesiology"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S2213-2600(21)00323-4","article-title":"Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: An open-label, phase 3, randomised controlled, non-inferiority trial.","volume":"9","author":"Meiser","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/aas.14010","article-title":"Isoflurane promotes early spontaneous breathing in ventilated intensive care patients: A post hoc subgroup analysis of a randomized trial.","volume":"66","author":"M\u00fcller\u2010Wirtz","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/BF03020665","article-title":"A comparison of sevoflurane with halothane, enflurane, and isoflurane on bronchoconstriction caused by histamine.","volume":"41","author":"Katoh","year":"1994","journal-title":"Can J Anaesth"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bja.2022.02.031","article-title":"Avoiding kidney damage in ICU sedation with sevoflurane: Use isoflurane instead.","volume":"129","author":"Sneyd","year":"2022","journal-title":"Br J Anaesth"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-004-2187-7","article-title":"Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients.","volume":"30","author":"Anzueto","year":"2004","journal-title":"Intensive Care Med"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.","volume":"351","author":"Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00540-021-02960-6","article-title":"Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients\u2014a retrospective chart review.","volume":"35","author":"Kermad","year":"2021","journal-title":"J Anesth"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PCC.0b013e3182772e29","article-title":"Volatile anesthetic rescue therapy in children with acute asthma: Innovative but costly or just costly?","volume":"14","author":"Char","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/pan.14295","article-title":"Volatile anesthetic agents for life\u2010threatening pediatric asthma: A multicenter retrospective cohort study and narrative review.","volume":"31","author":"Lew","year":"2021","journal-title":"Pediatric Anesthesia"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/bja\/aet257","article-title":"Sevoflurane therapy for life-threatening asthma in children.","volume":"111","author":"Schutte","year":"2013","journal-title":"Br J Anaesth"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"1051468","DOI":"10.3389\/fmed.2022.1051468","article-title":"Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation.","volume":"9","author":"Gill","year":"2022","journal-title":"Front Med"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s12630-014-0213-y","article-title":"Sevoflurane therapy for life-threatening acute severe asthma: A case report.","volume":"61","author":"Ruszkai","year":"2014","journal-title":"Can J Anaesth"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S0265021507001330","article-title":"Elimination of sevoflurane is reduced in plasma-tight compared to conventional membrane oxygenators.","volume":"25","author":"Prasser","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/jama.2025.3169","article-title":"Inhaled sedation in acute respiratory distress syndrome: The SESAR randomized clinical trial.","volume":"333","author":"Jabaudon","year":"2025","journal-title":"JAMA"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:25Z","timestamp":1753891225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001295","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}